 | September 1, 2006
By:Tony Pinsonault
Formularies, like managed care in general, are in a constant state of evolution.
 |
 | December 1, 2007
By:Tony Pinsonault
The implementation of the new Medicare Part D prescription-drug benefit in 2006 helped create a "perfect storm" for U.S. pharmaceutical and biotechnology manufacturers.
|
 | May 1, 2007
By:Bill Barr
Formularies are often described using terms such as "open," meaning all products are available, and "closed," meaning that only certain products are available. However, given the complex nature of pharmacy-benefit design, these terms are inadequate as labels to describe formularies.
|
 | February 1, 2007
By:Gwen McLean
Your ability to view prescribing data is minimal.
|
 | January 1, 2007
By:Bill Barr
To maximize sales in a managed care environment, pharmaceutical representatives must identify the "true payers" who assume the financial risk for their products.
|
June 1, 2006
By:Tony Pinsonault
What you need to know now that Part D is reality.
|
 | March 1, 2006
By:Christian Pinsonault, Tony Pinsonault
When reps understand how physicians are paid, they gain insights into how financial factors influence prescribing behavior. Then they can fine-tune their messages to help address physician needs while ensuring appropriate utilization of their products.
|
November 1, 2005
By:Susan Vargas
A Q&A with Richard Stefanacci.
|
| 
